Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07377903Not yet recruiting
Randomised, double-blind trial comparing Mg sulphate group, dexmedetomidine group and ondansetron group (3 arms). Primary endpoint: Time to cessation of shivering after drug administration at 6 hours. Planned start Feb 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07377903.